Brief: Sensei Biotherapeutics Inc Cash Runway Into Q2 Of 2026
28/03/2025 11:49
March 28 (Reuters) - Sensei Biotherapeutics Inc SNSE.O: SENSEI BIOTHERAPEUTICS INC -CASH RUNWAY INTO Q2 OF 2026 Source text: ID:nGNXbzD01s Further company coverage: SNSE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Faeth Therapeutics
See all newsU.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
Faeth Therapeutics rises after FDA grants fast-track status for cancer drug
Brief: Faeth Therapeutics Announces FDA Grant Of Fast Track Designation For Piktor Plus Paclitaxel In Biomarker-Selected Advanced Endometrial Cancer
Brief: Faeth Therapeutics Strengthens Executive Team With Senior Leadership Appointments